Over 10 mio. titler Fri fragt ved køb over 499,- Hurtig levering Forlænget returret til 31/01/25

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies

Forfatter: info mangler
Bog
  • Format
  • Bog, hardback
  • Engelsk

Beskrivelse

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines and cancer therapy. This thorough reference on the latest trends in the development of diverse modalities will appeal to a broad community of scientists, students and clinicians. Written by leading authors across academia and industry, this book covers important topics such as unique drug delivery devices, non-parenteral delivery trends, novel approaches to the treatment of cancer, immunotherapy and more. It includes real-world cases and examples which highlight formulations with therapeutic proteins, monoclonal antibodies, peptides and biobetters, as well as cases on novel vaccines formulations including evolving pathogens, novel modalities of vaccines, universal vaccines. This book is a thorough and useful resource on the development of novel biologics, vaccines and cancer therapies.

Læs hele beskrivelsen
Detaljer
  • SprogEngelsk
  • Sidetal520
  • Udgivelsesdato05-01-2015
  • ISBN139780124166035
  • Forlag Academic Press Inc
  • FormatHardback
Størrelse og vægt
  • Vægt1370 g
  • coffee cup img
    10 cm
    book img
    19,1 cm
    23,5 cm

    Findes i disse kategorier...

    Se andre, der handler om...

    Cancer Nanotechnology Ethics Clinical trials Drug targeting Immune System Nanoparticles. Peptides Gene silencing Liposomes Affinity chromatography Protein engineering Cytokines Cancer vaccines Blood-brain barrier Polyethylene glycol Central Nervous System Immunotherapy Glutathione Long-term memory Nanomedicine Drug Discovery Epigenomics Next generation sequencing Cellular response Pharmaceuticals Nanotherapeutics Immunotherapies Immunomodulators Biological barriers Antibody engineering Drug-Delivery Cancer immunotherapy Immunogenicity PD-1 Oncolytic viruses IDO CTLA-4 Brain cancer Glycoengineering Endocrine treatment Neurological Disorders Clinical development Mucosal Neurodegenerative Allergen DNA Vaccine Half life EPR effect PD-L1 Nab Prognostication Bispecifics ADCC Adjuvant cytotoxic chemotherapy Affinity Maturation Adoptive transfer anticarcinogens antigen-specific antibodies avidity Antibody-dependent cellular cytotoxicity (ADCC) Antibody-dependent cellular phagocytosis (ADCP) antibody-drug conjugate antibody structure-function biobetter Breadth of protection chicken antibodies Chemical proteomics Chimeric Antigen Receptors cross-presentation Ctl Checkpoint inhibitors Fc enhancement complement-dependent cytotoxicity (CDC) High-throughput technologies immunostimulatory genes EBV-specific T cells Effector function immunocontraceptives Fc fusion Fc-gamma receptor (FcγR) non-infectious neonatal Fc receptor (FcRn) microparticle next-generation gene sequencing non-cancer novel adjuvants germline genetic variation good clinical practice oral delivery of vaccines Immunoscore® immunostimulators humoral response long-circulating mucosal routes neutralizing monoclonal antibody (mAb) multispecifics prime/boost Pegylation
    Machine Name: SAXO083